Erbitux Inquiry Could Yield Pre-Approval Speech Bill – Rep. Greenwood

The House Energy & Commerce Committee is still interested in pursuing legislation to increase FDA's authority to regulate pre-approval promotions as a follow-up to the Erbitux investigation

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet